EU institutions should engage more politically to induce change in HIV awareness
14 Jul 2017 – 10:30 | No Comment

Nearly 122,000 are unaware of their HIV infection in Europe. To decrease the number of people who are diagnosed late or are unaware of their infection, new strategies are required to expand targeted HIV testing …

Read the full story »
International

EU Health

Transport

Circular Economy

Climate Change

Home » Archive by Category

Articles in Healthcare Policy

‘Let’s strive to reduce inequalities in access to medicines’
14 Jul 2017 – 10:50
‘Let’s strive to reduce inequalities in access to medicines’

Increasing patient literacy and reducing inequalities in access to drugs and treatment mechanisms is crucial in fighting breast cancer in Europe. Karin Kadenbach MEP, co-chair of the European Parliament Interest Group on Access to Healthcare …

Will access to innovative cancer drugs bankrupt European healthcare?
14 Jul 2017 – 10:40
Will access to innovative cancer drugs bankrupt European healthcare?

Dr Martine J Piccart  and Dr Noam Ponde from Institut Jules Bordet make an extensive study of the European drug scenario and note that a major reform in drug development is necessary, with “risk sharing” …

EU institutions should engage more politically to induce change in HIV awareness
14 Jul 2017 – 10:30
EU institutions should engage more politically to induce change in HIV awareness

Nearly 122,000 are unaware of their HIV infection in Europe. To decrease the number of people who are diagnosed late or are unaware of their infection, new strategies are required to expand targeted HIV testing …

European Commission’s passionate response to AIDS
14 Jul 2017 – 10:20
European Commission’s passionate response to AIDS

Thirty years since the first cases of AIDS were reported, the European Commission has been providing funding and support to several developing countries across the globe. Neven Mimica, European Commissioner for International Development and Cooperation …

‘Harmonised reimbursement approach key to reducing treatment inequalities’
14 Jul 2017 – 10:07
‘Harmonised reimbursement approach key to reducing treatment inequalities’

Personalised breast cancer treatment for patients in Europe should be a priority, however a discordant reimbursement process means that many cannot access vital tests to prevent under or over treatment. Dr Marjolaine Baldo, EMEA Commercial …

The European plan of action to end AIDS
14 Jul 2017 – 10:01
The European plan of action to end AIDS

The threat of HIV/AIDS has receded in several countries across the world. However, eastern Europe and Central Asia are exceptions to this. The number of newly reported HIV cases are increasing ever so fast in …

Optimising prostate cancer care, providing patients with best outcomes
14 Jul 2017 – 10:00
Optimising prostate cancer care, providing patients with best outcomes

Innovative genomic-based diagnostic technologies can help patients and healthcare professionals to assess risk and personalise treatment. Claire Takizawa and Juliette Plun-Favreau from Genomic Health explain why barriers to equal access should be urgently addressed
Prostate cancer …

A radical vision to beat prostate cancer in Europe
14 Jul 2017 – 09:30
A radical vision to beat prostate cancer in Europe

An increasing trend in the incidence of prostate cancer (PCa) has been observed in almost all European countries over the last few decades. There are no population-based, organised programmes for PCa in Europe as existing …

Integrating patient preference into treatment decisions prove crucial
14 Jul 2017 – 09:25
Integrating patient preference into treatment decisions prove crucial

Director of the European Cancer Patient Coalition, Dr Lydia Makaroff, writes that patients should be partners in their own treatments, as well as empowered to offer insights and practical recommendations to improve policy
The rates of …

Recent advances in personalised medicine in lung cancer – how can the benefits be leveraged throughout Europe?
14 Jul 2017 – 09:20
Recent advances in personalised medicine in lung cancer – how can the benefits be leveraged throughout Europe?

Michael Koehler, Commercial Portfolio Lead and Jason Almond, Brand Director, Oncology International Developed Markets at Pfizer discuss why it is imperative to support routine biomarker testing for lung cancer in Europe
Despite the highest mortality rates …